Hepatitis Associated Vasculitic Multiple Mononeuropathy

History and clinical findings:
A 56-year-old woman with hepatitis C had symptoms of a polyneuropathy with asymmetrical distal pareses and painful sensory disturbances in the limbs.

Investigation:
In addition to positive serology for hepatitis C cryoglobulins were demonstrated and complement C4 was reduced. Biopsy of the sural nerve showed a vasculitic neuropathy.

Treatment and course:
The multiple neuropathy (cryoglobulinaemic neuropathy), associated with hepatitis C, was treated with corticosteroids (starting with 60 mg/d prednisolone) and the neurological abnormalities regressed well.

Conclusion:
Vasculitis associated with hepatitis C should be included in the differential diagnosis of peripheral neuropathy.

Author: HECKMANN JG, UNIV ERLANGEN NURNBERG, NEUROL KLIN, SHWABACHANLAGE 6 D-91054 ERLANGEN, GERMANY Source: DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 1997 FEB28;122(9):259-262


Back to A Hepatitis C Primer

Advertisement

Hepatitis C Primer Home

What is Hepatitis How is Hepatitis Transmitted

Long-term Prognosis

Complications of HCV Liver Biopsy Treatment Info (Interferon, Herbal, etc) Lab Tests (PCR, Genotype,etc.) Nutrition & Alternative Info

Patient Information (Support Groups, Doctor Listing, etc) Related Webpages Transplant Info Site Search HCV Webrings Guestbook FAQ & Disclaimers

15 Tips for Managing Interferon-Ribavirin Side Effects
Finding new ways to manage the side effects of Hepatitis C combination therapy adds to a person’s likelihood of conquering the virus....

New Mexico Offers Free Hepatitis C Hotline
Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about...

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...

More Hep C articles ...